TransCode Therapeutics, Inc. · BOATS:RNAZ

TransCode Therapeutics, Inc. financial statements

TransCode Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue0000000
Cost of revenue114.2K534.9K516.7K98.6K42.5K
Gross profit-114.2K-534.9K-516.7K-98.6K-42.5K
Research and development13.4M9.71M12.3M10.2M2.75M284.5K226.3K82.5K
Selling, general and administrative5.77M5.95M7.15B8.43M3.40M442.1K230.6K301.5K
Operating income-28.0M-15.7M-19.4M-18.6M-6.15M-726.6K-456.9K-384.0K
Depreciation and amortization13.4K90.9K123.5K98.6K42.5K042.5K384.0K
EBITDA-28.0M-15.6M-19.3M-18.5M-6.11M-726.6K-414.4K0
Interest expense6.62K26.8K55.9K32.0K95.1K394.6K157.0K0
Income before tax-34.4M-16.8M-18.5M-17.6M-6.84M-2.34M-607.2K-453.4K
Income tax226.1K00053.1K0156.9K-69.4K
Net income-34.7M-16.8M-18.5M-17.6M-6.84M-2.34M-607.2K-453.4K
Earnings per share, basic-52.59-1,336.63-3,419.01-1,082.79-0.81-0.51-94.77
Earnings per share, diluted-52.59-1,336.63-3,419.01-1,082.79-0.81-0.51

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents17.8M5.81M2.77M4.97M20.8M828.0K204.5K213.0K
Short-term investments9.41K93
Receivables3.25M360.2K
Inventory554.3K
Current assets22.0M7.09M4.46M7.38M22.7M831.2K204.5K214.6K
Property, plant and equipment370.7K51.6K120.7K208.6K206.3K
Goodwill25.7M0
Total assets162.4M7.29M5.17M7.59M22.9M1.06M216.7K214.6K
Accounts payable3.12M2.58M2.33M4.12M2.02M369.2K27.3K
Current liabilities3.49M2.77M3.49M4.35M2.53M404.9K62.9K117.7K
Long-term debt2.09M927.8K
Total debt38.3K450.6K2.09M927.8K471.9K
Total liabilities10.5M9.31M3.53M4.35M2.53M4.46M1.31M718.6K
Shareholders' equity10.3M-2.02M1.64M3.24M20.4M-3.41M-1.10M-504.0K
Shares outstanding917.0K36.8K19.0K16.2K12.9M4.64M6.41K192

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-19.5M-13.3M-18.1M-15.8M-5.27M-493.0K-508.5K-299.6K
Capital spending-6.66K-21.8K-35.6K-100.9K-254.8K-254.8K-254.8K-254.8K
Free cash flow-19.5M-13.4M-18.1M-15.9M-5.52M-493.0K-508.5K-299.6K
Cash from investing-4.44K-21.8K-35.6K-100.9K-251.8K-251.8K-251.8K-251.8K
Cash from financing31.5M16.4M15.9M5.99K25.5M1.12M500.0K512.4K
Dividends paid-1.61B-30.6M
Change in cash12.0M3.04M-2.20M-15.9M20.0M623.5K-8.51K212.9K